Search by Drug Name or NDC

NDC 50242-0930-01 Hemlibra 300 mg/2mL Details

Hemlibra 300 mg/2mL

Hemlibra is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Genentech, Inc.. The primary component is EMICIZUMAB.

MedlinePlus Drug Summary

Emicizumab-kxwh injection is used to prevent or reduce the frequency of bleeding in adults, children, and infants with hemophilia A (condition in which the blood does not clot normally because of a missing or faulty blood clotting factor). Emicizumab-kxwh is in a class of medications called hemostatic antibodies. It works by acting as a bridge between clotting factors to help your blood clot.

Related Packages: 50242-0930-01
Last Updated: 04/14/2024
MedLinePlus Full Drug Details: Emicizumab-kxwh Injection

Product Information

NDC	50242-0930
Product ID	50242-930_bbf98231-9308-4099-9808-a170a48fdfb3
Associated GPIs
GCN Sequence Number	085644
GCN Sequence Number Description	emicizumab-kxwh VIAL 300 MG/2ML SUBCUT
HIC3	M0P
HIC3 Description	HEMOPHILIA TREATMENT AGENTS,NON-FACTOR REPLACEMENT
GCN	55163
HICL Sequence Number	044640
HICL Sequence Number Description	EMICIZUMAB-KXWH
Brand/Generic	Brand
Proprietary Name	Hemlibra
Proprietary Name Suffix	n/a
Non-Proprietary Name	emicizumab
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION, SOLUTION
Route	SUBCUTANEOUS
Active Ingredient Strength	300
Active Ingredient Units	mg/2mL
Substance Name	EMICIZUMAB
Labeler Name	Genentech, Inc.
Pharmaceutical Class	n/a
DEA Schedule	n/a
Marketing Category	BLA
Application Number	BLA761083
Listing Certified Through	2024-12-31

Package

NDC 50242-0930-01 (50242093001)

Pricing Information	N/A
NDC Package Code	50242-930-01
Billing NDC	50242093001
Package	1 VIAL, SINGLE-USE in 1 CARTON (50242-930-01) / 2 mL in 1 VIAL, SINGLE-USE
Marketing Start Date	2023-03-16
NDC Exclude Flag	N